ICU铜绿假单胞菌肺炎30例临床分析及耐药研究(2)
 |
| 第1页 |
参见附件(1104KB，2页)。
[2]李革,卢仙娥,邓济苏,等.重症监护病房获得性感染与传播机制研究[J].中华医院感染学杂志,2000,10(6):404-406.
[3]Lee S, Park YJ, Kim M, et al. Prevalence of Ambler class A and D [beta]- lactamases among clinical isolates of Pseudomonas aeruginosa in Korea [J]. J Antimicrob Chemother,2005,56(l):122-127.
[4]中华医学会呼吸病学分会.医院获得性肺感染诊断和治疗指南[J].中华结核和呼吸杂志,2003,22(4):201-202.
[5]刘蓉,周黎明,王浴生.铜绿假单胞菌对β-内酰胺类抗生素耐药机制[J].四川生理科学杂志,2004,26(4):148-152.
[6]吴爱武,郑贵星,江锋利,等.铜绿假单胞菌ESBL和AmpC酶表型检出与耐药性分析[J].中国卫生检验杂志,2006,16(1):88-103.
[7]Clinical and Laboratory Standards Institute(CLSI)/National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S].Fifteenth informational supplement M100-S15,2005.
[8]CLSI.Performance standards for antimicrobial susceptibility testing [S]. Seventeenth informational supplement M100-S17,2007.
[9]Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognezing the unusual and inferring resistance mechanisms from resistance phenotypes[J].J Antimicrob Chemother,2001,48(suppl 1):87-102.
(收稿日期:2008-11-14)
您现在查看是摘要介绍页，详见PDF附件(1104KB，2页)。